The Expression of Immunomodulation-Related Cytokines and Genes of Adipose- and Bone Marrow-Derived Human Mesenchymal Stromal Cells from Early to Late Passages

Chin Hee Mun, Mi Il Kang, Yong Dae Shin, Yeseul Kim, Yong Beom Park

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND:: Mesenchymal stromal cells (MSCs) are multipotent stem cells that can differentiate into several cell types. In addition, many studies have shown that MSCs modulate the immune response. However, little information is currently available regarding the maintenance of immunomodulatory characteristics of MSCs through passages. Therefore, we investigated and compared cytokine and gene expression levels from adipose (AD) and bone marrow (BM)-derived MSCs relevant to immune modulation from early to late passages. METHODS:: MSC immunophenotype, growth characteristics, cytokine expressions, and gene expressions were analyzed. RESULTS:: AD-MSCs and BM-MSCs had similar cell morphologies and surface marker expressions from passage 4 to passage 10. Cytokines secreted by AD-MSCs and BM-MSCs were similar from early to late passages. AD-MSCs and BM-MSCs showed similar immunomodulatory properties in terms of cytokine secretion levels. However, the gene expressions of tumor necrosis factor-stimulated gene (TSG)-6 and human leukocyte antigen (HLA)-G were decreased and gene expressions of galectin-1 and -3 were increased in both AD- and BM-MSCs with repeated passages. CONCLUSION:: Our study showed that the immunophenotype and expression of immunomodulation-related cytokines of AD-MSCs and BM-MSCs immunomodulation through the passages were not significantly different, even though the gene expressions of both MSCs were different.

Original languageEnglish
Pages (from-to)771-779
Number of pages9
JournalTissue Engineering and Regenerative Medicine
Volume15
Issue number6
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Immunomodulation
Mesenchymal Stromal Cells
Bone
Gene expression
Genes
Bone Marrow
Cytokines
Cell growth
Antigens
Stem cells
Gene Expression
Modulation
Galectin 1
Multipotent Stem Cells
Galectin 3

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

@article{a0d37a0fc11e48649686fc267aa0c81b,
title = "The Expression of Immunomodulation-Related Cytokines and Genes of Adipose- and Bone Marrow-Derived Human Mesenchymal Stromal Cells from Early to Late Passages",
abstract = "BACKGROUND:: Mesenchymal stromal cells (MSCs) are multipotent stem cells that can differentiate into several cell types. In addition, many studies have shown that MSCs modulate the immune response. However, little information is currently available regarding the maintenance of immunomodulatory characteristics of MSCs through passages. Therefore, we investigated and compared cytokine and gene expression levels from adipose (AD) and bone marrow (BM)-derived MSCs relevant to immune modulation from early to late passages. METHODS:: MSC immunophenotype, growth characteristics, cytokine expressions, and gene expressions were analyzed. RESULTS:: AD-MSCs and BM-MSCs had similar cell morphologies and surface marker expressions from passage 4 to passage 10. Cytokines secreted by AD-MSCs and BM-MSCs were similar from early to late passages. AD-MSCs and BM-MSCs showed similar immunomodulatory properties in terms of cytokine secretion levels. However, the gene expressions of tumor necrosis factor-stimulated gene (TSG)-6 and human leukocyte antigen (HLA)-G were decreased and gene expressions of galectin-1 and -3 were increased in both AD- and BM-MSCs with repeated passages. CONCLUSION:: Our study showed that the immunophenotype and expression of immunomodulation-related cytokines of AD-MSCs and BM-MSCs immunomodulation through the passages were not significantly different, even though the gene expressions of both MSCs were different.",
author = "Mun, {Chin Hee} and Kang, {Mi Il} and Shin, {Yong Dae} and Yeseul Kim and Park, {Yong Beom}",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s13770-018-0147-5",
language = "English",
volume = "15",
pages = "771--779",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "6",

}

The Expression of Immunomodulation-Related Cytokines and Genes of Adipose- and Bone Marrow-Derived Human Mesenchymal Stromal Cells from Early to Late Passages. / Mun, Chin Hee; Kang, Mi Il; Shin, Yong Dae; Kim, Yeseul; Park, Yong Beom.

In: Tissue Engineering and Regenerative Medicine, Vol. 15, No. 6, 01.12.2018, p. 771-779.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Expression of Immunomodulation-Related Cytokines and Genes of Adipose- and Bone Marrow-Derived Human Mesenchymal Stromal Cells from Early to Late Passages

AU - Mun, Chin Hee

AU - Kang, Mi Il

AU - Shin, Yong Dae

AU - Kim, Yeseul

AU - Park, Yong Beom

PY - 2018/12/1

Y1 - 2018/12/1

N2 - BACKGROUND:: Mesenchymal stromal cells (MSCs) are multipotent stem cells that can differentiate into several cell types. In addition, many studies have shown that MSCs modulate the immune response. However, little information is currently available regarding the maintenance of immunomodulatory characteristics of MSCs through passages. Therefore, we investigated and compared cytokine and gene expression levels from adipose (AD) and bone marrow (BM)-derived MSCs relevant to immune modulation from early to late passages. METHODS:: MSC immunophenotype, growth characteristics, cytokine expressions, and gene expressions were analyzed. RESULTS:: AD-MSCs and BM-MSCs had similar cell morphologies and surface marker expressions from passage 4 to passage 10. Cytokines secreted by AD-MSCs and BM-MSCs were similar from early to late passages. AD-MSCs and BM-MSCs showed similar immunomodulatory properties in terms of cytokine secretion levels. However, the gene expressions of tumor necrosis factor-stimulated gene (TSG)-6 and human leukocyte antigen (HLA)-G were decreased and gene expressions of galectin-1 and -3 were increased in both AD- and BM-MSCs with repeated passages. CONCLUSION:: Our study showed that the immunophenotype and expression of immunomodulation-related cytokines of AD-MSCs and BM-MSCs immunomodulation through the passages were not significantly different, even though the gene expressions of both MSCs were different.

AB - BACKGROUND:: Mesenchymal stromal cells (MSCs) are multipotent stem cells that can differentiate into several cell types. In addition, many studies have shown that MSCs modulate the immune response. However, little information is currently available regarding the maintenance of immunomodulatory characteristics of MSCs through passages. Therefore, we investigated and compared cytokine and gene expression levels from adipose (AD) and bone marrow (BM)-derived MSCs relevant to immune modulation from early to late passages. METHODS:: MSC immunophenotype, growth characteristics, cytokine expressions, and gene expressions were analyzed. RESULTS:: AD-MSCs and BM-MSCs had similar cell morphologies and surface marker expressions from passage 4 to passage 10. Cytokines secreted by AD-MSCs and BM-MSCs were similar from early to late passages. AD-MSCs and BM-MSCs showed similar immunomodulatory properties in terms of cytokine secretion levels. However, the gene expressions of tumor necrosis factor-stimulated gene (TSG)-6 and human leukocyte antigen (HLA)-G were decreased and gene expressions of galectin-1 and -3 were increased in both AD- and BM-MSCs with repeated passages. CONCLUSION:: Our study showed that the immunophenotype and expression of immunomodulation-related cytokines of AD-MSCs and BM-MSCs immunomodulation through the passages were not significantly different, even though the gene expressions of both MSCs were different.

UR - http://www.scopus.com/inward/record.url?scp=85056998139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056998139&partnerID=8YFLogxK

U2 - 10.1007/s13770-018-0147-5

DO - 10.1007/s13770-018-0147-5

M3 - Article

AN - SCOPUS:85056998139

VL - 15

SP - 771

EP - 779

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 6

ER -